切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - NO Donors / Precursors - BCPCF efflux - Inward Rectifier Potassium (Kir) Channels - MK2

12件产品中的 1-10

页面
每页
清除全部
  1. MK2 Inhibitor IV
    C5545 MK2 Inhibitor IV
    Target: MK2
    Summary: 高选择性、非ATP竞争性MK2抑制剂
      insoluble in DMSO
      ≥37.4 mg/mL
  2. Sodium Tauroursodeoxycholate (TUDC)
    B6019 Sodium Tauroursodeoxycholate (TUDC)
    中文名: 牛磺熊去氧胆酸钠
    Target: BCPCF efflux
    Summary: 水溶性胆汁盐
      ≥26.1 mg/mL
      ≥8.42 mg/mL
  3. CMPD-1
    B6962 CMPD-1
    Target: Microtubules/Tubulins|MK2
    Summary: p38α介导的MK2a磷酸化的抑制剂
      <34.94 mg/mL
      <34.94 mg/mL
  4. PF-3644022
    B5549 PF-3644022
    Target: MK2
    Summary: MK2抑制剂
      <14.98 mg/mL
  5. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  6. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  7. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  8. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. TAK-242
    A3850 TAK-242
     7 Citation
    中文名: 瑞沙托维
    Target: Toll-like receptors (TLRs)|NO Donors / Precursors|IL Receptors
    Summary: TLR 4信号抑制剂
      ≥18.09 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页